Related Experiment Video

Updated: Jun 1, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Management of upper respiratory tract infections in children

Mf Cotton1, S Innes, H Jaspan

  • 1Paediatric Infectious Diseases Unit, Department of Paediatrics and Child Health, Stellenbosch University.

South African Family Practice : Official Journal of the South African Academy of Family Practice/Primary Care
|May 24, 2011
PubMed

Insights

Upper respiratory tract infections (URTIs) are common viral illnesses causing mild illness and societal costs. This review focuses on rhinovirus, a key pathogen in URTIs, exploring its epidemiology and interactions.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Upper respiratory tract infections (URTIs) are prevalent in all age groups, leading to significant morbidity and societal burden.
  • These infections contribute to school and work absenteeism, increased healthcare utilization, and potential severe complications.
  • Numerous viruses cause URTIs, including rhinovirus, coronavirus, influenza virus, and respiratory syncytial virus (RSV).

Purpose of the Study:

  • To provide a comprehensive review of upper respiratory tract infections (URTIs).
  • To focus specifically on the rhinovirus, detailing its epidemiology, natural history, and pathogenic relationships.
  • To highlight recent advancements in understanding rhinovirus infections.

Main Methods:

  • Literature review of scientific articles and research papers.
  • Synthesis of epidemiological data on URTI prevalence and causative agents.
  • Analysis of studies focusing on rhinovirus, including its transmission, clinical manifestations, and co-infections.

Main Results:

  • URTIs represent a substantial public health challenge due to their high incidence and associated costs.
  • Rhinovirus is identified as a primary viral agent responsible for a significant proportion of URTIs.
  • Advances in research have elucidated key aspects of rhinovirus epidemiology and its role alongside other pathogens.

Conclusions:

  • Effective management and prevention strategies for URTIs require a thorough understanding of their viral etiology, particularly rhinovirus.
  • Further research into rhinovirus is crucial for mitigating its impact on individual health and societal resources.
  • Recognizing the complex interplay between different respiratory viruses can inform public health interventions.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...